Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Published Online: 2016-02-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alberto Chiappori•Ali Zeaiter•Alice T Shaw•Bo H Chao•Bogdana Balas•D Ross Camidge•Gregory J Riely•Hossein Borghaei•Howard West•Jeremy Cetnar•Kathryn A Gold•Leena Gandhi•Mark A Socinski•Oscar Puig•Sai-Hong Ignatius Ou•Shirish Gadgeel•Tarek Mekhail•Volkmar Henschel•Walter Bordogna
